CRP and endothelial dysfunction: On the other hand, the absence of correlation between CRP and FMD in lithiasis patients initially rules out systemic inflammation as a pathogenic step causing endothelial dysfunction in renal stone patients, and therefore, does not allow us to use it as an inflammatory serum marker of endothelial dysfunction in urolithiasis.